Get Live Data

PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Ondine Biomed Share Price
  4. Ondine Biomed Share Regulatory News
  5. Completion of Nominated Adviser due diligence

Pin to quick picksOndine Biomed Regulatory News (OBI)

Ondine Biomed Information

Share Price Information for Ondine Biomed (OBI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.75
Bid: 6.50
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 0.50 (7.692%)
Open: 6.75
High: 6.75
Low: 6.75
Prev. Close: 6.75
OBI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Nominated Adviser due diligence

26 Jul 2022 07:00

RNS Number : 6865T
Ondine Biomedical Inc.
26 July 2022
 

26 July 2022

Ondine Biomedical Inc.

("Ondine Biomedical", "Ondine" or the "Company")

Completion of Nominated Adviser due diligence

Ondine Biomedical Inc. (AIM: OBI) announces that Strand Hanson Limited, appointed as the Company's Nominated Adviser on 27 April 2022, has confirmed completion of its due diligence.

Pursuant to Schedule 2(g)(ii) of the AIM Rules for Companies, the following disclosures are required:

Director

Current directorships

Carolyn Cross

12673011 Canada Inc.

Nicolas Loebel

Advanced Photodynamic Technologies Inc.

Axcess Medical Inc.

Ondine Research Laboratories Ltd

 

For more information, please visit: www.ondinebio.com or contact: 

 

Ondine Biomedical Inc.

Carolyn Cross, CEO +001 (1) 604 669 0555

 

Strand Hanson Limited (Nominated and Financial Adviser)

Richard Johnson, James Harris, James Dance +44 (0) 20 7409 3494

 

Arden Partners plc (Broker)

Ruari McGirr +44 (0) 20 7614 5900

 

Vane Percy & Roberts (Media Contact)

Simon Vane Percy, Amanda Bernard +44 (0) 77 1000 5910

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKPBKDBKBBOB
123
Date   Source Headline
13th May 20249:30 amRNSNOTIFICATION OF MAJOR HOLDINGS
10th May 20247:00 amRNSECDC report shows rising HAIs and antibiotic use
8th May 20247:00 amRNSFurther Result of Fundraising
3rd May 20244:27 pmRNSResult of Fundraising
3rd May 20248:00 amRNSOndine announces proposed fundraising
2nd May 20246:25 pmRNSRelated Party Transactions
25th Apr 20247:00 amRNSNew study confirms nose is key source of infection
24th Apr 20247:00 amRNSCorporate and Trading Update
22nd Apr 20247:00 amRNSSteriwave in first Australian hospital
15th Apr 20247:00 amRNS32% Fewer SSIs After Steriwave Replaced Mupirocin
10th Apr 20247:00 amRNSSteriwave authorized for use by HCA UK
4th Apr 20247:00 amRNSEntry into ICU market expands revenue potential
28th Mar 202412:52 pmRNSAppointment of Interim Chief Financial Officer
25th Mar 20247:00 amRNSFirst commercial adoption of Steriwave by the NHS
21st Mar 20247:00 amRNSSteriwave study shows 77% drop in antibiotic use
15th Mar 20245:10 pmRNSReplacement: Steriwave deploying in 8 new sites
15th Mar 20247:00 amRNSSteriwave deploying in eight new sites
5th Mar 20249:45 amRNSOndine starts first UK health economics study
31st Jan 20247:00 amRNSMicrobiome research supports use of Steriwave
26th Jan 20247:00 amRNSOndine unveils new research at SPIE Photonics West
26th Jan 20247:00 amRNSGrant of Share Options
16th Jan 20248:15 amRNSAppointment of new Chief Financial Officer
13th Dec 20237:00 amRNSC$4.91 raise supports ongoing commercialisation
12th Dec 20231:20 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
11th Dec 20236:15 pmRNSResult of Fundraising
5th Dec 20237:00 amRNSResult of Placing & Broker Option Update
4th Dec 20231:28 pmRNSClose of Bookbuild
1st Dec 20236:13 pmRNSUpdate. Re investor-led financing
30th Nov 20236:40 pmRNSOndine announces investor-led financing
16th Nov 20237:00 amRNSPhotodisinfection recommended as Standard of Care
31st Oct 20239:00 amRNSSteriwave use expanded following successful pilot
23rd Oct 20237:00 amRNS66.5% reduction in spine surgery infection rate
18th Oct 20237:00 amRNSSteriwave shown to reduce resistant bacteria
13th Oct 20237:00 amRNSSteriwave now in Canada's East Coast
10th Oct 20239:00 amRNSOndine to present poster at IP2023, Liverpool
9th Oct 20237:00 amRNSHospital to adopt Steriwave as standard-of-care
29th Sep 20239:00 amRNSBurnaby Hospital deploys Steriwave
25th Sep 20239:00 amRNSHalf-year Report
21st Sep 20237:00 amRNSMontreal Heart Institute pilots Steriwave
14th Sep 202312:00 pmRNSSteriwave proven effective against XDR bacteria
12th Sep 20239:00 amRNSSteriwave evaluation at major heart institute
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
29th Aug 20239:30 amRNSOndine to present new AMR research at ICPIC Geneva
21st Aug 20237:00 amRNSIssue of Equity and TVR
7th Aug 20239:00 amRNSOndine technology used in major Canadian hospital
1st Aug 20237:00 amRNSOndine commences first NHS Steriwave® pilot
17th Jul 202310:04 amRNSOndine receives impact award at IPA World Congress
7th Jul 20235:58 pmRNSCorporate Update
22nd Jun 20239:00 amRNSPhotodisinfection cuts COVID in meat processing
25th May 20237:00 amRNSResult of AGM
123

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.